Mumbai : Mitsu Chem Plast Limited (Mitsu) (BSE:540078), one of the leading global manufacturers of Blow moulded & Injection Moulded products and a specialist in hospital furniture components, Infrastructure Products, Packaging Bottles Drums, Jerrycan, Pails and Caps, has announced its Audited Financial Results for Q4 FY25 & FY25.
Key Financial Highlights
Q4 FY25
- Total Income of ₹ 90.51 Cr, YoY growth of 9.64%
- EBITDA of ₹ 8.23 Cr, YoY growth of 9.39%
- PAT of ₹ 3.54 Cr, YoY growth of 25.11%
- PAT Margin of 3.91%, YoY growth of 47 Bps
- EPS of ₹ 2.61, YoY growth of 14.98%
Commenting on the performance, Mr. Jagdish Dedhia, Chairman of Mitsu Chem Plast Limited said, In FY25, we delivered a total income of ₹ 332.88 Cr, an EBITDA of ₹ 23.28 Cr, a PAT of ₹ 7.25 Cr and an EPS of ₹ 5.39, figures that underscore the resilience and balanced execution of our business model.
We`re also proud of the strong export momentum we`ve built, proof of our product quality and the trust of partners around the world which has paved the way for Furnastra, our dedicated healthcare-furniture brand designed to meet rising demand for durable, ergonomic solutions in hospitals and care facilities. Sustainability underpins everything we do, from sourcing eco-friendly materials to driving energy and waste efficiencies in our operations.
Looking ahead, we`ve set our sights on reaching the ₹ 1,000 Cr milestone by 2028 a goal that extends our 35-year legacy of innovation and customer focus. It`s not just about scaling revenues; it`s about improving patient care worldwide through Furnastra`s advanced polymer solutions. With our export strength, targeted brand expansion, and unwavering commitment to sustainable practices, we`re well-positioned to capture new opportunities and deliver lasting value for all stakeholders.
